Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

Pfizer

Status and phase: Completed; Phase 3

Conditions: Anxiety Neuroses

Treatments: Drug: Pregabalin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00150449

1008-100

Details and patient eligibility

About

Determine long-term safety and tolerability of pregabalin in patients with anxiety disorders.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must have completed the double-blind portion of the preceding trial
• Completed any protocol specified withdrawal phase and follow-up visits.

Exclusion criteria

• Patient cannot participate if they experienced a serious adverse event or a nonserious, but medically significant adverse event during the preceding efficacy study that was judged to be related to the study medication.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)